• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄作为HBeAg阴性慢性乙型肝炎病毒感染且丙氨酸氨基转移酶持续正常时显著纤维化特征的预测指标。

Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.

作者信息

Tan Youwen, Ye Yun, Zhou Xinbei, Chen Li, Wen Danfeng

机构信息

Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China; Department of Hepatosis, The Third Hospital of Zhenjiang Affiliated Jiangsu University, Zhenjiang, China.

Department of Hepatosis, The Third Hospital of Zhenjiang Affiliated Jiangsu University, Zhenjiang, China.

出版信息

PLoS One. 2015 Apr 17;10(4):e0123452. doi: 10.1371/journal.pone.0123452. eCollection 2015.

DOI:10.1371/journal.pone.0123452
PMID:25885705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4401737/
Abstract

BACKGROUND

Although alanine aminotransferase (ALT) levels reflect the degree of liver damage, not all patients with chronic hepatitis B virus (HBV) infection exhibit persistently elevated ALT levels. In the present study, we aimed to comprehensively evaluate the characteristics of histological abnormalities in a large population of Chinese patients with chronic HBV and persistently normal ALT levels.

METHODS

In total, 2303 consecutive patients who underwent liver biopsy were screened. Of these patients, 273 were categorized as having persistently normal ALT levels (PNALT), whereas 618 were categorized as having persistently or intermittently elevated ALT levels (PIALT). All these patients had at least three ALT values recorded in the year prior to the baseline liver biopsy.

RESULTS

Significant necroinflammation was observed in 9.7% (11/113) patients with PNALT, 23.3% (42/180) patients with PIALT (ALT 1-2× upper limit of normal [ULN]), and 27.8% (42/151) patients with PIALT (ALT > 2× ULN), whereas significant fibrosis was observed in 8.8% (10/113) patients with PNALT, 27.8% (42/151) patients with PIALT (ALT 1-2× ULN), and 21.2% (32/151) patients with PIALT (ALT > 2× ULN). Multiple logistic regression analysis indicated that age parameters were associated with significant histological abnormalities in patients with PNALT. The area under the curve showed that age was associated with significant fibrosis characteristics in patients with hepatitis B extracellular antigen (HBeAg)-negative PNALT.

CONCLUSION

Significant histological abnormalities are not often observed in Chinese patients with PNALT. Interestingly, age appears to be a predictor of significant fibrosis in patients with HBeAg-negative PNALT.

摘要

背景

尽管丙氨酸氨基转移酶(ALT)水平反映了肝损伤程度,但并非所有慢性乙型肝炎病毒(HBV)感染患者的ALT水平都会持续升高。在本研究中,我们旨在全面评估一大群慢性HBV感染且ALT水平持续正常的中国患者的组织学异常特征。

方法

总共筛选了2303例连续接受肝活检的患者。在这些患者中,273例被归类为ALT水平持续正常(PNALT),而618例被归类为ALT水平持续或间歇性升高(PIALT)。所有这些患者在基线肝活检前一年至少记录了三个ALT值。

结果

在PNALT患者中,9.7%(11/113)出现显著坏死性炎症,在PIALT患者(ALT为正常上限[ULN]的1 - 2倍)中,23.3%(42/180)出现显著坏死性炎症,在PIALT患者(ALT > 2×ULN)中,27.8%(42/151)出现显著坏死性炎症;而在PNALT患者中,8.8%(10/113)出现显著纤维化,在PIALT患者(ALT为正常上限[ULN]的1 - 2倍)中,27.8%(42/151)出现显著纤维化,在PIALT患者(ALT > 2×ULN)中,21.2%(32/151)出现显著纤维化。多因素逻辑回归分析表明,年龄参数与PNALT患者的显著组织学异常相关。曲线下面积显示,年龄与乙肝e抗原(HBeAg)阴性的PNALT患者的显著纤维化特征相关。

结论

PNALT的中国患者中不常观察到显著的组织学异常。有趣的是,年龄似乎是HBeAg阴性的PNALT患者显著纤维化的一个预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b992/4401737/f4851f2e71f1/pone.0123452.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b992/4401737/0229ed7f5702/pone.0123452.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b992/4401737/e74e34e9da18/pone.0123452.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b992/4401737/f4851f2e71f1/pone.0123452.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b992/4401737/0229ed7f5702/pone.0123452.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b992/4401737/e74e34e9da18/pone.0123452.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b992/4401737/f4851f2e71f1/pone.0123452.g003.jpg

相似文献

1
Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.年龄作为HBeAg阴性慢性乙型肝炎病毒感染且丙氨酸氨基转移酶持续正常时显著纤维化特征的预测指标。
PLoS One. 2015 Apr 17;10(4):e0123452. doi: 10.1371/journal.pone.0123452. eCollection 2015.
2
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.在丙型肝炎病毒感染持续正常丙氨酸氨基转移酶患者中,FIB-4、天门冬氨酸氨基转移酶与血小板比值指数和肝硬度测量的诊断价值。
World J Gastroenterol. 2017 Aug 21;23(31):5746-5754. doi: 10.3748/wjg.v23.i31.5746.
3
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.慢性乙型肝炎病毒感染的无症状患者谷丙转氨酶持续正常时的病毒学和组织学特征
Gastroenterology. 2008 May;134(5):1376-84. doi: 10.1053/j.gastro.2008.02.075. Epub 2008 Feb 29.
4
The clinical significance of persistently normal ALT in chronic hepatitis B infection.慢性乙型肝炎感染中持续正常的丙氨酸氨基转移酶的临床意义。
J Hepatol. 2007 Dec;47(6):760-7. doi: 10.1016/j.jhep.2007.07.022. Epub 2007 Sep 24.
5
Significant histopathology in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase.中国慢性乙型肝炎患者持续正常高值丙氨酸氨基转移酶水平的显著组织病理学变化。
J Viral Hepat. 2010 Mar;17 Suppl 1:44-50. doi: 10.1111/j.1365-2893.2010.01270.x.
6
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.恩替卡韦治疗丙氨酸氨基转移酶轻度升高和活检证实有组织学损伤的慢性乙型肝炎患者的疗效。
Hepatology. 2010 Apr;51(4):1185-9. doi: 10.1002/hep.23424.
7
A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B.慢性乙型肝炎患者血清丙氨酸氨基转移酶水平正常但肝脏组织学改变的机制评估
PLoS One. 2015 Jul 31;10(7):e0134532. doi: 10.1371/journal.pone.0134532. eCollection 2015.
8
Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.国际指南识别乙型肝炎 e 抗原阴性慢性乙型肝炎患者显著纤维化的准确性。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1493-1499.e2. doi: 10.1016/j.cgh.2013.05.038. Epub 2013 Jun 28.
9
Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.评估正常或轻度升高的丙氨酸转氨酶、年龄和 DNA 水平在预测慢性乙型肝炎肝组织学变化中的作用。
Liver Int. 2011 Jul;31(6):824-30. doi: 10.1111/j.1478-3231.2011.02491.x. Epub 2011 Mar 6.
10
Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.在印度尼西亚,血清 ALT 低于正常值上限的 2 倍但 HBV-DNA 水平较高的慢性乙型肝炎患者中存在显著的肝脏组织病理学变化。
J Dig Dis. 2011 Dec;12(6):476-80. doi: 10.1111/j.1751-2980.2011.00540.x.

引用本文的文献

1
Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection: A Retrospective Study.阿曼HBeAg阴性慢性乙型肝炎病毒感染患者显著肝纤维化的患病率及危险因素:一项回顾性研究
Oman Med J. 2024 Nov 30;39(6):e693. doi: 10.5001/omj.2024.113. eCollection 2024 Nov.
2
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase.未治疗的不确定期慢性乙型肝炎患者的肝脏组织学变化。
World J Hepatol. 2024 Jun 27;16(6):920-931. doi: 10.4254/wjh.v16.i6.920.
3
Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage.

本文引用的文献

1
Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.恩替卡韦对丙氨酸氨基转移酶持续正常的慢性乙型肝炎患者的疗效:随机、双盲、安慰剂对照研究。
Antivir Ther. 2014;19(8):755-64. doi: 10.3851/IMP2754. Epub 2014 Feb 28.
2
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.用于非酒精性脂肪性肝病中肝脂肪变性检测和定量的受控衰减参数
J Gastroenterol Hepatol. 2014;29(7):1470-6. doi: 10.1111/jgh.12557.
3
Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALT.
慢性乙型肝炎患者若持续丙氨酸氨基转移酶正常或年龄<30 岁,可能存在显著的组织学损伤。
BMC Gastroenterol. 2024 Mar 27;24(1):120. doi: 10.1186/s12876-024-03208-9.
4
Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.用于预测 HBeAg 阴性慢性乙型肝炎病毒感染且丙氨酸氨基转移酶正常患者中显著肝组织病理学的非侵入性血清标志物。
Microbiol Spectr. 2024 Apr 2;12(4):e0394123. doi: 10.1128/spectrum.03941-23. Epub 2024 Mar 1.
5
Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients.非肝硬化乙肝e抗原阴性患者停用富马酸替诺福韦二吡呋酯和恩替卡韦后的肝炎发作或肝失代偿
J Clin Med. 2023 Dec 8;12(24):7565. doi: 10.3390/jcm12247565.
6
qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT Levels.qHBsAg 用于识别 ALT 水平正常和轻度升高的 HBeAg 阴性慢性乙型肝炎患者的肝组织学异常。
Can J Gastroenterol Hepatol. 2022 Jul 14;2022:8695196. doi: 10.1155/2022/8695196. eCollection 2022.
7
The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase.代谢因素和脂肪变性在初治慢性乙型肝炎且丙氨酸氨基转移酶正常患者中的作用
Infect Dis Ther. 2022 Jun;11(3):1133-1148. doi: 10.1007/s40121-022-00629-5. Epub 2022 Apr 10.
8
The Relationship Between Collagen Proportionate Area and Hepatitis B Surface Antigen Levels in E Antigen Positive Hepatitis B Cirrhosis.肝硬变患者乙型肝炎 e 抗原阳性时胶原比例面积与乙型肝炎表面抗原水平的关系
Turk J Gastroenterol. 2022 Jan;33(1):62-67. doi: 10.5152/tjg.2022.20796.
9
Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection.宿主阴性因素对乙型肝炎病毒感染中干扰素-α治疗反应的抑制作用。
Front Med (Lausanne). 2021 Nov 24;8:784172. doi: 10.3389/fmed.2021.784172. eCollection 2021.
10
Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis.初治的丙氨酸氨基转移酶水平正常的乙型肝炎患者中显著组织学改变并不罕见:一项荟萃分析
J Clin Transl Hepatol. 2021 Oct 28;9(5):615-625. doi: 10.14218/JCTH.2020.00136. Epub 2021 May 6.
中国慢性乙型肝炎患者谷丙转氨酶持续正常或轻度升高的组织学特征比较。
PLoS One. 2013 Nov 18;8(11):e80585. doi: 10.1371/journal.pone.0080585. eCollection 2013.
4
Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT.在中国慢性乙型肝炎患者中,持续正常 ALT 的患者中显著纤维化并不罕见。
PLoS One. 2013 Oct 25;8(10):e78672. doi: 10.1371/journal.pone.0078672. eCollection 2013.
5
Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT.比较 FIB-4 和 APRI 在持续正常 ALT 和轻度升高 ALT 的中国 HBV 感染患者中的应用。
J Viral Hepat. 2013 Apr;20(4):e3-10. doi: 10.1111/jvh.12010. Epub 2012 Nov 19.
6
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.富马酸替诺福韦二吡呋酯治疗慢性乙型肝炎时肝硬化的逆转:一项 5 年开放标签随访研究。
Lancet. 2013 Feb 9;381(9865):468-75. doi: 10.1016/S0140-6736(12)61425-1. Epub 2012 Dec 10.
7
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.牛磺胆酸钠共转运多肽是乙型肝炎病毒和丁型肝炎病毒的功能性受体。
Elife. 2012 Nov 13;1:e00049. doi: 10.7554/eLife.00049.
8
Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review.HBeAg 阴性慢性乙型肝炎病毒感染患者 ALT 持续正常时肝活检的随访及适应证:系统评价。
J Hepatol. 2012 Jul;57(1):196-202. doi: 10.1016/j.jhep.2011.11.030. Epub 2012 Mar 23.
9
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.欧洲肝脏研究学会临床实践指南:慢性乙型肝炎病毒感染的管理
J Hepatol. 2012 Jul;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. Epub 2012 Mar 20.
10
A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.一项大型人群组织学研究表明,慢性乙型肝炎中丙氨酸氨基转移酶(ALT)升高与显著纤维化之间缺乏关联。
PLoS One. 2012;7(2):e32622. doi: 10.1371/journal.pone.0032622. Epub 2012 Feb 28.